Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Public ClinicalTrials.gov record NCT03906331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Expanded access for participants with cancer with RET activation who are ineligible for an ongoing selpercatinib (also known as LOXO-292) clinical trial or have other considerations that prevent access to selpercatinib through an existing clinical trial. The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.
Study identification
- NCT ID
- NCT03906331
- Recruitment status
- Approved For Marketing
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jan 17, 2025
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cancer Treatment Centers of America | Goodyear | Arizona | 85338 | — |
| Mayo Clinic of Scottsdale | Scottsdale | Arizona | 85259 | — |
| City of Hope National Medical Center | Duarte | California | 91010-0269 | — |
| UCLA Medical Center | Los Angeles | California | 90095 | — |
| Kaiser Permanente | Oakland | California | 94612 | — |
| Irvine Medical Center | Orange | California | 92868 | — |
| University of California - San Diego | San Diego | California | 92103 | — |
| Univ of California San Francisco | San Francisco | California | 94115 | — |
| Kaiser Permanente | Santa Clara | California | 95051 | — |
| Kaiser Permanente Medical Center | Vallejo | California | 94589 | — |
| Memorial Cancer Institute | Hollywood | Florida | 33021 | — |
| Mayo Clinic in Florida | Jacksonville | Florida | 32224 | — |
| Florida Hospital | Orlando | Florida | 32803 | — |
| Tallahassee Memorial Cancer Center | Tallahassee | Florida | 32308 | — |
| University Cancer and Blood Center | Athens | Georgia | 30607 | — |
| Emory University | Atlanta | Georgia | 30329-5102 | — |
| University of Chicago Medicine-Comprehensive Cancer Center | Chicago | Illinois | 60637 | — |
| Cancer Treatment Centers of America | Zion | Illinois | 60099 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| START Midwest | Grand Rapids | Michigan | 49546 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Cancer Treatment Centers of America | Tulsa | Oklahoma | 74133 | — |
| University of Pennsylvania Hospital | Philadelphia | Pennsylvania | 19104 | — |
| Eastern Regional Medical Center | Philadelphia | Pennsylvania | 19124 | — |
| Oncology Consultants | Houston | Texas | 77030 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | — |
| University of Wisconsin-Madison Hospital and Health Clinic | Madison | Wisconsin | 53792-4108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03906331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03906331 live on ClinicalTrials.gov.